According to the terms of the agreement reached by both parties, Unleash will receive 1,136,364 preferred shares issued by TransCode Therapeutics.

老虎证券2026/03/03 13:49

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support

Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.

智通财经•2026/09/15 00:26

BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences

Reuters•2026/09/15 00:19

LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk

Dow Jones•2026/09/15 00:14

2-Yr Benchmark Govt Yields - Germany vs Other Nations

Dow Jones•2026/09/15 00:10